These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 29467573)
21. Phospholipid Vesicles for Dermal/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties. Natsheh H; Touitou E Molecules; 2020 Jun; 25(13):. PubMed ID: 32605117 [TBL] [Abstract][Full Text] [Related]
22. Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes. Ghanbarzadeh S; Arami S Biomed Res Int; 2013; 2013():616810. PubMed ID: 23936825 [TBL] [Abstract][Full Text] [Related]
24. Development and evaluation of the effect of ethanol and surfactant in vesicular carriers on Lamivudine permeation through the skin. Sudhakar K; Mishra V; Jain S; Rompicherla NC; Malviya N; Tambuwala MM Int J Pharm; 2021 Dec; 610():121226. PubMed ID: 34710540 [TBL] [Abstract][Full Text] [Related]
25. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Song CK; Balakrishnan P; Shim CK; Chung SJ; Chong S; Kim DD Colloids Surf B Biointerfaces; 2012 Apr; 92():299-304. PubMed ID: 22205066 [TBL] [Abstract][Full Text] [Related]
27. Comparative study of novel ultradeformable liposomes: menthosomes, transfersomes and liposomes for enhancing skin permeation of meloxicam. Duangjit S; Obata Y; Sano H; Onuki Y; Opanasopit P; Ngawhirunpat T; Miyoshi T; Kato S; Takayama K Biol Pharm Bull; 2014; 37(2):239-47. PubMed ID: 24225259 [TBL] [Abstract][Full Text] [Related]
28. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation. El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers. Duangjit S; Opanasopit P; Rojanarata T; Ngawhirunpat T AAPS PharmSciTech; 2013 Mar; 14(1):133-40. PubMed ID: 23242556 [TBL] [Abstract][Full Text] [Related]
30. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226 [TBL] [Abstract][Full Text] [Related]
31. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. Patel KK; Kumar P; Thakkar HP AAPS PharmSciTech; 2012 Dec; 13(4):1502-10. PubMed ID: 23104306 [TBL] [Abstract][Full Text] [Related]
32. Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation. Aziz DE; Abdelbary AA; Elassasy AI Drug Deliv; 2018 Nov; 25(1):815-826. PubMed ID: 29557244 [TBL] [Abstract][Full Text] [Related]
33. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. El-Laithy HM; Shoukry O; Mahran LG Eur J Pharm Biopharm; 2011 Jan; 77(1):43-55. PubMed ID: 21056658 [TBL] [Abstract][Full Text] [Related]
34. Transdermal delivery of flurbiprofen from surfactant-based vesicles: particle characterization and the effect of water on in vitro transport. Uchino T; Matsumoto Y; Murata A; Oka T; Miyazaki Y; Kagawa Y Int J Pharm; 2014 Apr; 464(1-2):75-84. PubMed ID: 24445120 [TBL] [Abstract][Full Text] [Related]
35. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. El Maghraby GM; Williams AC; Barry BW Int J Pharm; 2000 Feb; 196(1):63-74. PubMed ID: 10675708 [TBL] [Abstract][Full Text] [Related]
36. Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes. El Maghraby GM; Williams AC; Barry BW J Pharm Pharmacol; 2001 Oct; 53(10):1311-22. PubMed ID: 11697538 [TBL] [Abstract][Full Text] [Related]
37. Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment. Abidin L; Mujeeb M; Imam SS; Aqil M; Khurana D Drug Deliv; 2016; 23(3):1079-84. PubMed ID: 25116512 [TBL] [Abstract][Full Text] [Related]
38. Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model. Zeb A; Qureshi OS; Yu CH; Akram M; Kim HS; Kim MS; Kang JH; Majid A; Chang SY; Bae ON; Kim JK Int J Pharm; 2017 Jun; 525(1):92-100. PubMed ID: 28428089 [TBL] [Abstract][Full Text] [Related]
39. Enhancement of the bioavailability of an antihypertensive drug by transdermal protransfersomal system: formulation and in vivo study. Morsi NM; Aboelwafa AA; Dawoud MHS J Liposome Res; 2018 Jun; 28(2):137-148. PubMed ID: 28264602 [TBL] [Abstract][Full Text] [Related]
40. Fluidity enhancement: a critical factor for performance of liposomal transdermal drug delivery system. Sharma VK; Sarwa KK; Mazumder B J Liposome Res; 2014 Jun; 24(2):83-9. PubMed ID: 24160895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]